Platelet activating factor

Platelet activating factor is a lipid of Glycerophospholipids (GP) class. Platelet activating factor is associated with abnormalities such as Atherosclerosis, Acute cholecystitis without calculus, Cholecystitis, Colitis and Cholecystitis, Acute. The involved functions are known as Cell Survival, Metabolic Inhibition, lipid oxidation, Apoptosis and Oxidation. Platelet activating factor often locates in soluble, Cellular Membrane, Smooth muscle (tissue), Intima and Tissue specimen. The associated genes with Platelet activating factor are apolipoprotein A-I Milano, Homologous Gene, TSPO gene, HBEGF gene and SLC33A1 gene. The related lipids are Hydroxycholesterols, Liposomes, 25-hydroxycholesterol, Lysophosphatidylcholines and Lipopolysaccharides. The related experimental models are Knock-out, Mouse Model and Transgenic Model.

Cross Reference

Introduction

To understand associated biological information of Platelet activating factor, we collected biological information of abnormalities, associated pathways, cellular/molecular locations, biological functions, related genes/proteins, lipids and common seen animal/experimental models with organized paragraphs from literatures.

What diseases are associated with Platelet activating factor?

Platelet activating factor is suspected in Ischemia, Pleurisy, Atherosclerosis, Inflammatory disorder, Retinal Diseases, Diabetes and other diseases in descending order of the highest number of associated sentences.

Related references are mostly published in these journals:

Disease Cross reference Weighted score Related literature
Loading... please refresh the page if content is not showing up.

Possible diseases from mapped MeSH terms on references

We collected disease MeSH terms mapped to the references associated with Platelet activating factor

MeSH term MeSH ID Detail
Brain Hemorrhage, Traumatic D020201 1 associated lipids
Dictyocaulus Infections D004022 1 associated lipids
Migraine without Aura D020326 1 associated lipids
Mouth, Edentulous D009066 1 associated lipids
Anthrax D000881 1 associated lipids
Egg Hypersensitivity D021181 1 associated lipids
Arenaviridae Infections D001117 1 associated lipids
Leukostasis D018921 1 associated lipids
Pulmonary Atelectasis D001261 1 associated lipids
Neurologic Manifestations D009461 1 associated lipids
Leukocyte-Adhesion Deficiency Syndrome D018370 1 associated lipids
Chromoblastomycosis D002862 2 associated lipids
Hemorrhagic Fever, American D006478 2 associated lipids
Bovine Virus Diarrhea-Mucosal Disease D001912 2 associated lipids
Ileitis D007079 2 associated lipids
Peanut Hypersensitivity D021183 2 associated lipids
Jaundice, Obstructive D041781 2 associated lipids
Multiple Trauma D009104 2 associated lipids
Amnesia, Anterograde D020324 2 associated lipids
Soft Tissue Injuries D017695 2 associated lipids
Per page 10 20 50 100 | Total 288

PubChem Associated disorders and diseases

What pathways are associated with Platelet activating factor

There are no associated biomedical information in the current reference collection.

PubChem Biomolecular Interactions and Pathways

Link to PubChem Biomolecular Interactions and Pathways

What cellular locations are associated with Platelet activating factor?

Related references are published most in these journals:

Location Cross reference Weighted score Related literatures
Loading... please refresh the page if content is not showing up.

What functions are associated with Platelet activating factor?


Related references are published most in these journals:

Function Cross reference Weighted score Related literatures

What lipids are associated with Platelet activating factor?

Related references are published most in these journals:

Lipid concept Cross reference Weighted score Related literatures
Loading... please refresh the page if content is not showing up.

What genes are associated with Platelet activating factor?

Related references are published most in these journals:


Gene Cross reference Weighted score Related literatures

What common seen animal models are associated with Platelet activating factor?

Knock-out

Knock-out are used in the study 'A cardioprotective role for platelet-activating factor through NOS-dependent S-nitrosylation.' (Leary PJ et al., 2008).

Mouse Model

Mouse Model are used in the study 'A regulatory role of LPCAT1 in the synthesis of inflammatory lipids, PAF and LPC, in the retina of diabetic mice.' (Cheng L et al., 2009).

Transgenic Model

Transgenic Model are used in the study 'Heterogeneity in the sn-1 carbon chain of platelet-activating factor glycerophospholipids determines pro- or anti-apoptotic signaling in primary neurons.' (Ryan SD et al., 2008).

Related references are published most in these journals:

Model Cross reference Weighted score Related literatures
Loading... please refresh the page if content is not showing up.

NCBI Entrez Crosslinks

All references with Platelet activating factor

Download all related citations
Per page 10 20 50 100 | Total 8526
Authors Title Published Journal PubMed Link
Hynes AC et al. The phosphatidylinositol signalling system in elongating bovine blastocysts; formation of phosphoinositides, inositol phosphates and stimulation by growth factors. 2002 Reprod. Fertil. Dev. pmid:12617797
Li X and Luo H [Advances in pharmacological study of Piper kadsura (Choisy) Ohwi]. 2002 Zhong Yao Cai pmid:14748373
Kulikov VI and Muzya GI Influence of acyl and plasmalogenic analogs of platelet activating factor on chemotaxis of human leukocytes in vitro and their inflammatory and antiinflammatory activity in vivo. 2002 Biochemistry Mosc. pmid:12495421
Sibelius U et al. Distinct pathways of lipopolysaccharide priming of human neutrophil respiratory burst: role of lipid mediator synthesis and sensitivity to interleukin-10. 2002 Crit. Care Med. pmid:12394960
Pawliczak R et al. Oxidative stress induces arachidonate release from human lung cells through the epithelial growth factor receptor pathway. 2002 Am. J. Respir. Cell Mol. Biol. pmid:12444032
MacKinnon AC et al. Sphingosine kinase: a point of convergence in the action of diverse neutrophil priming agents. 2002 J. Immunol. pmid:12444147
Marrache AM et al. Proinflammatory gene induction by platelet-activating factor mediated via its cognate nuclear receptor. 2002 J. Immunol. pmid:12444157
Pacheco P et al. Lipopolysaccharide-induced leukocyte lipid body formation in vivo: innate immunity elicited intracellular Loci involved in eicosanoid metabolism. 2002 J. Immunol. pmid:12444160
Abe Y et al. Effect of a platelet-activating factor antagonist, E5880, on cerebrovasospasm following subarachnoid hemorrhage in a canine double-hemorrhage model. 2002 Eur. J. Pharmacol. pmid:12445578
Marathe GK et al. Activation of vascular cells by PAF-like lipids in oxidized LDL. 2002 Vascul. Pharmacol. pmid:12449015
Lacombe J et al. Antisense inhibition of Flk-1 by oligonucleotides composed of 2'-deoxy-2'-fluoro-beta-D-arabino- and 2'-deoxy-nucleosides. 2002 Can. J. Physiol. Pharmacol. pmid:12450061
Francescangeli E et al. Activation of PAF-synthesizing enzymes in rat brain stem slices after LTP induction in the medial vestibular nuclei. 2002 Neurochem. Res. pmid:12512951
Barbuti A et al. Block of the background K(+) channel TASK-1 contributes to arrhythmogenic effects of platelet-activating factor. 2002 Am. J. Physiol. Heart Circ. Physiol. pmid:12003807
Ryan KL et al. Platelet-activating factor does not mediate circulatory failure induced by 35-GHz microwave heating. 2002 Methods Find Exp Clin Pharmacol pmid:12168504
Takizawa T et al. Inhibition of protein kinases A and C demonstrates dual modes of response in human eosinophils stimulated with platelet-activating factor. 2002 J. Allergy Clin. Immunol. pmid:12170264
Sun Z et al. Effective treatment of gut barrier dysfunction using an antioxidant, a PAF inhibitor, and monoclonal antibodies against the adhesion molecule PECAM-1. 2002 J. Surg. Res. pmid:12121711
Mayer K et al. Omega-3 fatty acids suppress monocyte adhesion to human endothelial cells: role of endothelial PAF generation. 2002 Am. J. Physiol. Heart Circ. Physiol. pmid:12124231
Giorgi G et al. Mass spectrometric characterization of substituted 2-thiazolin-4-one derivatives. 2002 J Mass Spectrom pmid:12125004
Kulikov VI and Muzya GI Influence of platelet-activating factor, its cell analogs, and antagonist on the production of superoxide radicals by blood leukocytes of healthy and hypercholesterolemic individuals. 2002 Biochemistry Mosc. pmid:12126473
Leusch A et al. Altered drug disposition of the platelet activating factor antagonist apafant in mdr1a knockout mice. 2002 Eur J Pharm Sci pmid:12128165
Megens AA et al. Pharmacological profile of (2R-trans)-4-[1-[3,5-bis(trifluoromethyl)benzoyl]-2-(phenylmethyl)-4-piperidinyl]-N-(2,6-dimethylphenyl)-1-acetamide (S)-Hydroxybutanedioate (R116301), an orally and centrally active neurokinin-1 receptor antagonist. 2002 J. Pharmacol. Exp. Ther. pmid:12130734
Podolak-Dawidziak M [Role of white cells and neoplastic cells in haemostasis]. 2002 Pol. Arch. Med. Wewn. pmid:12189915
Kolaczkowska E et al. Early vascular permeability in murine experimental peritonitis is co-mediated by resident peritoneal macrophages and mast cells: crucial involvement of macrophage-derived cysteinyl-leukotrienes. 2002 Inflammation pmid:11989789
Ahamed J and Ali H Distinct roles of receptor phosphorylation, G protein usage, and mitogen-activated protein kinase activation on platelet activating factor-induced leukotriene C(4) generation and chemokine production. 2002 J. Biol. Chem. pmid:11934880
Teather LA et al. Platelet-activating factor increases prostaglandin E(2) release from astrocyte-enriched cortical cell cultures. 2002 Brain Res. pmid:12133598
De Plaen IG et al. Endotoxin, but not platelet-activating factor, activates nuclear factor-kappaB and increases IkappaBalpha and IkappaBbeta turnover in enterocytes. 2002 Immunology pmid:12153521
Akisu M et al. The effect of dietary supplementation with n-3 polyunsaturated fatty acids on the generation of platelet-activating factor and leukotriene B4 in hypoxic-ischemic brain in young mice. 2002 Prostaglandins Leukot. Essent. Fatty Acids pmid:12468264
Li L et al. Antiplatelet aggregation activity of diterpene alkaloids from Spiraea japonica. 2002 Eur. J. Pharmacol. pmid:12163102
Sakai H et al. Nitric oxide-induced Cl- secretion in isolated rat colon is mediated by the release of thromboxane A2. 2002 J. Physiol. (Lond.) pmid:12181297
Roudebush WE et al. Embryonic platelet-activating factor: temporal expression of the ligand and receptor. 2002 J. Assist. Reprod. Genet. pmid:11958508
Calcerrada MC et al. PAF-stimulated protein tyrosine phosphorylation in hippocampus: involvement of NO synthase. 2002 Neurochem. Res. pmid:11958533
Fragopoulou E et al. Biologically active lipids with antiatherogenic properties from white wine and must. 2002 J. Agric. Food Chem. pmid:11958642
Lloberas N et al. The ether phospholipids trail: blood timing in renal ischemia-reperfusion injury. 2002 Transplant. Proc. pmid:11959179
Castellvi J et al. Effect of the platelet-activating factor antagonist BN-52021 on liver preservation (4 degrees): experimental study in isolated reperfused rat liver model. 2002 Transplant. Proc. pmid:11959181
Wang LS et al. Effects of platelet activating factor, butyrate and interleukin-6 on cyclooxygenase-2 expression in human esophageal cancer cells. 2002 Scand. J. Gastroenterol. pmid:11989839
Börjesson A et al. Early treatment with lexipafant, a platelet-activating factor-receptor antagonist, is not sufficient to prevent pulmonary endothelial damage after intestinal ischaemia and reperfusion in rats. 2002 Dig Liver Dis pmid:11990391
Borgquist JD et al. Adhesion to extracellular matrix proteins modulates bovine neutrophil responses to inflammatory mediators. 2002 J. Leukoc. Biol. pmid:11994500
Kalkanci A et al. The role of tumour necrosis factor-alpha (TNF-alpha) and platelet-activating factor (PAF) interaction on murine candidosis. 2002 Mycoses pmid:12000505
Bernatchez PN et al. Relative effects of VEGF-A and VEGF-C on endothelial cell proliferation, migration and PAF synthesis: Role of neuropilin-1. 2002 J. Cell. Biochem. pmid:11968003
Hostettler ME et al. Platelet-activating factor induces cell death in cultured astrocytes and oligodendrocytes: involvement of caspase-3. 2002 Glia pmid:11968060
Boisfer E et al. Antioxidant properties of HDL in transgenic mice overexpressing human apolipoprotein A-II. 2002 J. Lipid Res. pmid:11971944
Kingston JK et al. Measurement of the activation of equine platelets by use of fluorescent-labeled annexin V, anti-human fibrinogen antibody, and anti-human thrombospondin antibody. 2002 Am. J. Vet. Res. pmid:11939312
Deo DD et al. Phosphorylation of STAT-3 in response to basic fibroblast growth factor occurs through a mechanism involving platelet-activating factor, JAK-2, and Src in human umbilical vein endothelial cells. Evidence for a dual kinase mechanism. 2002 J. Biol. Chem. pmid:11940567
Strait RT et al. Pathways of anaphylaxis in the mouse. 2002 J. Allergy Clin. Immunol. pmid:11941316
Xu N et al. Effects of platelet-activating factor, tumor necrosis factor, and interleukin-1alpha on the expression of apolipoprotein M in HepG2 cells. 2002 Biochem. Biophys. Res. Commun. pmid:11944906
Mohr PJ and Halcomb RL Convergent enantioselective synthesis of the tricyclic core of phomactin A. 2002 Org. Lett. pmid:12098260
Yoshida H et al. Platelet-activating factor enhances the expression of vascular endothelial growth factor in normal human astrocytes. 2002 Brain Res. pmid:12106666
Jaracz S et al. Ginkgolides: selective acetylations, translactonization, and biological evaluation. 2002 J. Org. Chem. pmid:12076171
Downing SJ et al. Effect of inflammatory mediators on the physiology of the human Fallopian tube. 2002 Hum Fertil (Camb) pmid:12082208
Honda Z et al. Platelet-activating factor receptor. 2002 J. Biochem. pmid:12038971
Lloberas N et al. Postischemic renal oxidative stress induces inflammatory response through PAF and oxidized phospholipids. Prevention by antioxidant treatment. 2002 FASEB J. pmid:12039876
Iatrou C et al. Is platelet-activating factor produced during hemodialysis with AN-69 polyacrylonitrile membrane? 2002 Nephron pmid:12021524
Acuña AA et al. Fluticasone propionate attenuates platelet-activating factor-induced gas exchange defects in mild asthma. 2002 Eur. Respir. J. pmid:12030727
Steel HC et al. Platelet-activating factor and lyso-PAF possess direct antimicrobial properties in vitro. 2002 APMIS pmid:12064871
Michibayashi T Platelet aggregating response to platelet activating factor participates in activation of the 12-lipoxygenase pathway in platelets from rabbits. 2002 Int Angiol pmid:12384648
Haynes J and Obiako B Activated polymorphonuclear cells increase sickle red blood cell retention in lung: role of phospholipids. 2002 Am. J. Physiol. Heart Circ. Physiol. pmid:11748055
Shigematsu S et al. Bradykinin-induced proinflammatory signaling mechanisms. 2002 Am. J. Physiol. Heart Circ. Physiol. pmid:12388246
Maul H et al. Local application of platelet-activating factor induces cervical ripening accompanied by infiltration of polymorphonuclear leukocytes in rats. 2002 Am. J. Obstet. Gynecol. pmid:12388958
Murohisa G et al. Involvement of platelet-activating factor in hepatic apoptosis and necrosis in chronic ethanol-fed rats given endotoxin. 2002 Liver pmid:12390475
Maniscalco M et al. Nitric oxide attenuates platelet-activating factor induced nasal airway plasma extravasation in healthy subjects. 2002 Eur. J. Clin. Invest. pmid:12423328
Dun Y et al. Activated polymorphonuclear leukocytes induce cardiomyocyte apoptosis and the protective effects of carvedilol. 2002 Methods Find Exp Clin Pharmacol pmid:12428428
Arai H Platelet-activating factor acetylhydrolase. 2002 Prostaglandins Other Lipid Mediat. pmid:12432911
Fallani A et al. Synthesis of platelet-activating factor (PAF) in transformed cell lines of a different origin. 2002 Prostaglandins Other Lipid Mediat. pmid:12428690
Ishii S et al. Platelet-activating factor receptor. 2002 Prostaglandins Other Lipid Mediat. pmid:12432946
Gélinas DS et al. Immediate and delayed VEGF-mediated NO synthesis in endothelial cells: role of PI3K, PKC and PLC pathways. 2002 Br. J. Pharmacol. pmid:12429574
Mahmoud FF et al. In vitro effects of ginkgolide B combined with cyclosporin A on T-lymphocyte activation and IL-5 expression in peripheral blood mononuclear cells from asthmatic subjects. 2002 Transplant. Proc. pmid:12431672
Bussolati B et al. Expression of CD154 on renal cell carcinomas and effect on cell proliferation, motility and platelet-activating factor synthesis. 2002 Int. J. Cancer pmid:12209602
Cadwallader KA et al. Regulation of phosphatidylinositol 3-kinase activity and phosphatidylinositol 3,4,5-trisphosphate accumulation by neutrophil priming agents. 2002 J. Immunol. pmid:12218155
Bussolati B et al. Nitric oxide/platelet activating factor cross-talk in mesangial cells modulates the interaction with leukocytes. 2002 Kidney Int. pmid:12234302
Weyrich AS et al. Platelets, endothelial cells, inflammatory chemokines, and restenosis: complex signaling in the vascular play book. 2002 Circulation pmid:12234942
Han SJ et al. Molecular mechanisms for lipopolysaccharide-induced biphasic activation of nuclear factor-kappa B (NF-kappa B). 2002 J. Biol. Chem. pmid:12235132
Akai T et al. Modulation of tissue-type plasminogen activator expression by platelet activating factor in human glioma cells. 2002 J. Neurooncol. pmid:12241114
Ibe BO et al. Metabolism of platelet activating factor by intrapulmonary vascular smooth muscle cells. Effect of oxygen on phospholipase A2 protein expression and activities of acetyl-CoA acetyltransferase and cholinephosphotransferase. 2002 Mol. Genet. Metab. pmid:12409272
Childs EW et al. In vivo visualization of reactive oxidants and leukocyte-endothelial adherence following hemorrhagic shock. 2002 Shock pmid:12412620
Sakai H et al. E3040 sulphate, a novel thromboxane synthase inhibitor, blocks the Cl- secretion induced by platelet-activating factor in isolated rat colon. 2002 Br. J. Pharmacol. pmid:12023941
Breschi MC et al. Protective effect of silymarin in antigen challenge- and histamine-induced bronchoconstriction in in vivo guinea-pigs. 2002 Eur. J. Pharmacol. pmid:11864645
Tanaka Y et al. Anti-CD44 monoclonal antibody (IM7) induces murine systemic shock mediated by platelet activating factor. 2002 J. Autoimmun. pmid:11869042
Teruel MN and Meyer T Parallel single-cell monitoring of receptor-triggered membrane translocation of a calcium-sensing protein module. 2002 Science pmid:11884760
Matorras R and Pijoan JI The improvement in pregnancy rates with platelet-activating factor in intrauterine insemination was not demonstrated. 2002 Am. J. Obstet. Gynecol. pmid:11904634
McClenahan DJ et al. In vitro evaluation of the role of platelet-activating factor and interleukin-8 in Mannheimia haemolytica-induced bovine pulmonary endothelial cell injury. 2002 Am. J. Vet. Res. pmid:11911574
Schwartzkopff F et al. The CXC chemokine NAP-2 mediates differential heterologous desensitization of neutrophil effector functions elicited by platelet-activating factor. 2002 J. Interferon Cytokine Res. pmid:11911809
Royal SJ et al. Laminar disorganisation of mitral cells in the olfactory bulb does not affect topographic targeting of primary olfactory axons. 2002 Brain Res. pmid:11911856
Ko HM et al. Nuclear factor kappaB dependency of platelet-activating factor-induced angiogenesis. 2002 Cancer Res. pmid:11912159
Ishiguro K et al. Bisxanthones from Hypericum japonicum: inhibitors of PAF-induced hypotension. 2002 Planta Med. pmid:11914965
Barabé F et al. Cholesterol-modulating agents selectively inhibit calcium influx induced by chemoattractants in human neutrophils. 2002 J. Biol. Chem. pmid:11839753
Mio T et al. Lysophosphatidic acid augments fibroblast-mediated contraction of released collagen gels. 2002 J. Lab. Clin. Med. pmid:11873241
Klein A et al. Platelet-activating factor drives eotaxin production in an allergic pleurisy in mice. 2002 Br. J. Pharmacol. pmid:11877329
Bulger EM et al. The macrophage response to endotoxin requires platelet activating factor. 2002 Shock pmid:11900334
Mitsuoka H et al. Protease inhibition in the intestinal lumen: attenuation of systemic inflammation and early indicators of multiple organ failure in shock. 2002 Shock pmid:11900339
Talvani A et al. Leukotriene B(4) induces nitric oxide synthesis in Trypanosoma cruzi-infected murine macrophages and mediates resistance to infection. 2002 Infect. Immun. pmid:12117933
Fonteh AN Differential effects of arachidonoyl trifluoromethyl ketone on arachidonic acid release and lipid mediator biosynthesis by human neutrophils. Evidence for different arachidonate pools. 2002 Eur. J. Biochem. pmid:12153573
Walterscheid JP et al. Platelet-activating factor, a molecular sensor for cellular damage, activates systemic immune suppression. 2002 J. Exp. Med. pmid:11805144
Unno N et al. Association of a G994 -->T missense mutation in the plasma platelet-activating factor acetylhydrolase gene with risk of abdominal aortic aneurysm in Japanese. 2002 Ann. Surg. pmid:11807372
Johansson S et al. A neutrophil multitarget functional bioassay to detect anti-inflammatory natural products. 2002 J. Nat. Prod. pmid:11809061
Chmiel B [The influence of select pathophysiologic factors of acute pancreatitis on erythrocytes' deformability examined in vitro]. 2002 Wiad. Lek. pmid:12715347
Nagase T et al. Airway hyperresponsiveness in transgenic mice overexpressing platelet activating factor receptor is mediated by an atropine-sensitive pathway. 2002 Am. J. Respir. Crit. Care Med. pmid:11790655
Roudebush WE et al. Relationship between platelet-activating factor concentration in rhesus monkey (Macaca mulatta) spermatozoa and sperm motility. 2002 Am. J. Primatol. pmid:11793409
Furukawa M et al. Presence of platelet-activating factor in nasal polyps and eosinophils. 2002 Acta Otolaryngol. pmid:12542208
Drost EM and MacNee W Potential role of IL-8, platelet-activating factor and TNF-alpha in the sequestration of neutrophils in the lung: effects on neutrophil deformability, adhesion receptor expression, and chemotaxis. 2002 Eur. J. Immunol. pmid:11813158
Claing A et al. Comparison of the contractile and calcium-increasing properties of platelet-activating factor and endothelin-1 in the rat mesenteric artery and vein. 2002 Br. J. Pharmacol. pmid:11815379